Evidence map›Paper›PMID 38468266›Full record

ArticleImplementation science : IS2024

Comparative effectiveness of implementation strategies for Accelerating Cervical Cancer Elimination through the integration of Screen-and-treat Services (ACCESS study): protocol for a cluster randomized hybrid type III trial in Nigeria.

Babayemi O Olakunde, Ijeoma U Itanyi, John O Olawepo, Lin Liu, Chinenye Bembir, Ngozi Idemili-Aronu, Nwamaka N Lasebikan, Tonia C Onyeka, Cyril C Dim, Chibuike O Chigbu and 2 more

Registry-linked trialAbstract readClinical Trial Protocol
In one paragraph

Article in Implementation science : IS, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT06128304 (ACCESS), which is not on this map. Cited by 5 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT06128304 narecruitingnot on this map

ACCESS: Accelerating Cervical Cancer Elimination Through the Integration of Screen-and-treat Services

TypeinterventionalSponsorUniversity of California, San DiegoRan2023 to 2027Enrolled2,436ConditionsHIV, Cervical CancerArmsCore Implementation strategies, Core+ Enhanced Implementation Strategies
3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Babayemi O OlakundeDepartment of Community Prevention and Care Services, National Agency for the Control of AIDS, Abuja, Nigeria.
Ijeoma U ItanyiCenter for Translation and Implementation Research, University of Nigeria Nsukka, Enugu, Nigeria.
John O OlawepoCenter for Translation and Implementation Research, University of Nigeria Nsukka, Enugu, Nigeria.
Lin LiuHerbert Wertheim School of Public Health & Human Longevity Science, University of California San Diego, La Jolla, CA, USA.
Chinenye BembirCenter for Translation and Implementation Research, University of Nigeria Nsukka, Enugu, Nigeria.
Ngozi Idemili-AronuCenter for Translation and Implementation Research, University of Nigeria Nsukka, Enugu, Nigeria.
Nwamaka N LasebikanCenter for Translation and Implementation Research, University of Nigeria Nsukka, Enugu, Nigeria.
Tonia C OnyekaCenter for Translation and Implementation Research, University of Nigeria Nsukka, Enugu, Nigeria.
Cyril C DimCenter for Translation and Implementation Research, University of Nigeria Nsukka, Enugu, Nigeria.
Chibuike O ChigbuCenter for Translation and Implementation Research, University of Nigeria Nsukka, Enugu, Nigeria.
Echezona E EzeanolueCenter for Translation and Implementation Research, University of Nigeria Nsukka, Enugu, Nigeria.
Gregory A AaronsDepartment of Psychiatry, University of California San Diego, La Jolla, CA, 92093-0812, USA. gaarons@ucsd.edu.ORCID 0000-0001-8969-5002

Funding

Enhancing team effectiveness for a collaborative school-based intervention for ADHDP50MH126231 · NIMH · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI GREGORY AARONS, LAUREN BROOKMAN-FRAZEE · 2022 to 2026
$13.9M
Statewide System and Organizational Strategy for Evidence-Based Practice Implementation and Sustainment in Substance Use Disorder TreatmentR01DA049891 · NIDA · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI AARONS, GREGORY · 2020 to 2024
$3.6M
ACCESS: Accelerating Cervical Cancer Elimination through the integration of Screen-and-treat ServicesU01CA275118 · NCI · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI GREGORY AARONS, Echezona Edozie Ezeanolue · 2022 to 2026
$3.5M
Testing the Leadership and Organizational Change for Implementation (LOCI) Intervention in Substance Abuse Treatment ProgramsR01DA038466 · NIDA · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI AARONS, GREGORY · 2015 to 2019
$3.0M
Strengthening Research Administration Infrastructure for HIV Research in NigeriaG11TW011841 · FIC · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI AARONS, GREGORY, EZEANOLUE, ECHEZONA EDOZIE · 2022 to 2024
$307k
FIC NIH HHS G11 TW011841FIC NIH HHS G11TW011841NCI NIH HHS U01 CA275118NIDA NIH HHS R01 DA038466NIDA NIH HHS R01 DA049891NIMH NIH HHS P50 MH126231
6 · The paper itself

Abstract

backgroundDespite the increased risk of cervical cancer (CC) among women living with HIV (WLHIV), CC screening and treatment (CCST) rates remain low in Africa. The integration of CCST services into established HIV programs in Africa can improve CC prevention and control. However, the paucity of evidence on effective implementation strategies (IS) has limited the success of integration in many countries. In this study, we seek to identify effective IS to enhance the integration of CCST services into existing HIV programs in Nigeria.

methodsOur proposed study has formative and experimental activities across the four phases of the Exploration, Preparation, Implementation, and Sustainment (EPIS) framework. Through an implementation mapping conducted with stakeholders in the exploration phase, we identified a core package of IS (Core) and an enhanced package of IS (Core+) mostly selected from the Expert Recommendations for Implementing Change. In the preparation phase, we refined and tailored the Core and Core+ IS with the implementation resource teams for local appropriateness. In the implementation phase, we will conduct a cluster-randomized hybrid type III trial to assess the comparative effectiveness of Core versus Core+. HIV comprehensive treatment sites (k = 12) will be matched by region and randomized to Core or Core+ in the ratio of 1:1 stratified by region. In the sustainment phase, we will assess the sustainment of CCST at each site. The study outcomes will be assessed using RE-

aimreach (screening rate), adoption (uptake of IS by study sites), IS fidelity (degree to which the IS occurred according to protocol), clinical intervention fidelity (delivery of CC screening, onsite treatment, and referral according to protocol), clinical effectiveness (posttreatment screen negative), and sustainment (continued integrated CCST service delivery). Additionally, we will descriptively explore potential mechanisms, including organizational readiness, implementation climate, CCST self-efficacy, and implementation intentions. DISCUSSION: The assessment of IS to increase CCST rates is consistent with the global plan of eliminating CC as a public health threat by 2030. Our study will identify a set of evidence-based IS for low-income settings to integrate evidence-based CCST interventions into routine HIV care in order to improve the health and life expectancy of WLHIV.

trial registrationProspectively registered on November 7, 2023, at ClinicalTrials.gov no. NCT06128304. https://classic. CLINICALTRIALS: gov/ct2/show/study/NCT06128304.

Indexed as

HIV InfectionsUterine Cervical NeoplasmsFemaleHumansNigeriaRandomized Controlled Trials as TopicSelf EfficacyAfricaCervical cancerImplementation scienceNigeriaRE-AIMWomen living with HIV, EPIS framework, Exploration, Preparation, Implementation, and Sustainment framework

Identifiers

PMID38468266
PMCPMC10926605

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.